Bridged nucleoside and nucleotide using same
AssigneesOsaka University, Japan AS Represented By Director General of National Institute of Health Sciences
InventorsSatoshi Obika, Takao Yamaguchi, Hibiki Komine, Takaya Sugiura, Takao Inoue, Tokuyuki Yoshida
Life of this patent
Estimating the term…
Abstract
Disclosed are a bridged nucleoside and a nucleotide using the same. The nucleoside of the present invention is represented by the formula (I) below. The bridged nucleoside of the present invention is usable as a substitute for a phosphorothioate-modified nucleic acid, which has a risk of, for example, accumulation in a specific organ. The bridged nucleoside also has excellent industrial productivity.
Claims10
A compound represented by a formula (I-1) below or a salt thereof:
- where Base represents a purin-9-yl group that may have any one or more substituents selected from an α group, or a 2-oxo-1,2-dihydropyrimidin-1-yl group that may have any one or more substituents selected from the α group, the α group consisting of a hydroxy group, a hydroxy group protected by a protecting group for nucleic acid synthesis, linear alkyl groups having 1 to 6 carbon atoms, linear alkoxy groups having 1 to 6 carbon atoms, a mercapto group, a mercapto group protected by a protecting group for nucleic acid synthesis, linear alkylthio groups having 1 to 6 carbon atoms, an amino group, linear alkylamino groups having 1 to 6 carbon atoms, an amino group protected by a protecting group for nucleic acid synthesis, and halogen atoms,
- R2 and R3 each independently represent a hydrogen atom, a hydroxy group protecting group for nucleic acid synthesis, an alkyl group having 1 to 7 carbon atoms that may form a branch or a ring, an alkenyl group having 2 to 7 carbon atoms that may form a branch or a ring, an aryl group having 3 to 10 carbon atoms that may have any one or more substituents selected from the α group and may have a heteroatom, an aralkyl group with an aryl moiety having 3 to 12 carbon atoms that may have any one or more substituents selected from the α group and may have a heteroatom, an acyl group that may have any one or more substituents selected from the α group, a silyl group that may have any one or more substituents selected from the α group, a phosphate group that may have any one or more substituents selected from the α group, a phosphate group protected by a protecting group for nucleic acid synthesis, or —P(R4a)R5a, where R4a and R5a each independently represent a hydroxy group, a hydroxy group protected by a protecting group for nucleic acid synthesis, a mercapto group, a mercapto group protected by a protecting group for nucleic acid synthesis, an amino group, an alkoxy group having 1 to 6 carbon atoms, an alkylthio group having 1 to 6 carbon atoms, a cyanoalkoxy group having 1 to 6 carbon atoms, or a dialkylamino group that has an alkyl group having 1 to 6 carbon atoms,
- X2 is an oxygen atom, a sulfur atom, —NH—, —N(CH3)—, or a methylene group, and
- R6 and R7 are each independently a hydrogen atom, a linear alkyl group having 1 to 3 carbon atoms, —NHR4b, where R4b is a hydrogen atom or a linear alkyl group having 1 to 3 carbon atoms, or —OR5b, where R5b is a hydrogen atom or a linear alkyl group having 1 to 3 carbon atoms.
An oligonucleotide containing at least one nucleoside structure represented by a formula (II-1) below or a pharmacologically acceptable salt thereof:
- where Base represents a purin-9-yl group that may have any one or more substituents selected from an α group, or a 2-oxo-1,2-dihydropyrimidin-1-yl group that may have any one or more substituents selected from the α group, the α group consisting of a hydroxy group, a hydroxy group protected by a protecting group for nucleic acid synthesis, linear alkyl groups having 1 to 6 carbon atoms, linear alkoxy groups having 1 to 6 carbon atoms, a mercapto group, a mercapto group protected by a protecting group for nucleic acid synthesis, linear alkylthio groups having 1 to 6 carbon atoms, an amino group, linear alkylamino groups having 1 to 6 carbon atoms, an amino group protected by a protecting group for nucleic acid synthesis, and halogen atoms;
- X2 is an oxygen atom, a sulfur atom, —NH—, —N(CH3)—, or a methylene group, and
- R6 and R7 are each independently a hydrogen atom, a linear alkyl group having 1 to 3 carbon atoms, —NHR4b, where R4b is a hydrogen atom or a linear alkyl group having 1 to 3 carbon atoms, or —OR5b, where R5b is a hydrogen atom or a linear alkyl group having 1 to 3 carbon atoms.
Dependencies are inferred from the claim text.